Literature DB >> 25830045

Liver regeneration following repeat SBRT.

Andrew Farach1, Jorge Quesada1, Bin S Teh1.   

Abstract

Liver stereotactic body radiation therapy (SBRT) is an emerging treatment option for oligometastases and may confer a survival benefit in select patients. Herein, we document the first case of liver regeneration (LR) following repeat right hepatic lobe SBRT in a woman with breast cancer metastases. Retraction of the treated lobe was significant with a near 50% volume reduction. Compensatory contralateral lobe hypertrophy was noted with a 320% volume increase. The overall liver volume remained stable, within ±5% of baseline. This case indicates that repeat liver SBRT can be delivered safely to individual patients and that compensatory contralateral lobe hypertrophy is observed to maintain a functional liver volume.

Entities:  

Keywords:  Liver regeneration (LR); cirrhosis; metastasis; radiation; stereotactic; stereotactic body radiation therapy (SBRT)

Year:  2015        PMID: 25830045      PMCID: PMC4311083          DOI: 10.3978/j.issn.2078-6891.2014.082

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  18 in total

Review 1.  Partial volume tolerance of the liver to radiation.

Authors:  Laura A Dawson; Randall K Ten Haken
Journal:  Semin Radiat Oncol       Date:  2005-10       Impact factor: 5.934

2.  Selection of patients for resection of hepatic colorectal metastases: expert consensus statement.

Authors:  Chusilp Charnsangavej; Bryan Clary; Yuman Fong; Axel Grothey; Timothy M Pawlik; Michael A Choti
Journal:  Ann Surg Oncol       Date:  2006-09-01       Impact factor: 5.344

3.  Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy.

Authors:  C C Olsen; J Welsh; B D Kavanagh; W Franklin; M McCarter; H R Cardenes; L E Gaspar; T E Schefter
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-11-05       Impact factor: 7.038

4.  Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis.

Authors:  N Nagasue; H Yukaya; Y Ogawa; H Kohno; T Nakamura
Journal:  Ann Surg       Date:  1987-07       Impact factor: 12.969

5.  The human liver after radiation injury. A form of veno-occlusive disease.

Authors:  G B Reed; A J Cox
Journal:  Am J Pathol       Date:  1966-04       Impact factor: 4.307

6.  Cell proliferation in the regenerating liver and the effect of prior continuous irradiation.

Authors:  J I Fabrikant
Journal:  Radiat Res       Date:  1967-12       Impact factor: 2.841

7.  Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study.

Authors:  Alejandra Méndez Romero; Wouter Wunderink; Shahid M Hussain; Jacco A De Pooter; Ben J M Heijmen; Peter C J M Nowak; Joost J Nuyttens; Rene P Brandwijk; Cees Verhoef; Jan N M Ijzermans; Peter C Levendag
Journal:  Acta Oncol       Date:  2006       Impact factor: 4.089

Review 8.  Repeat hepatectomy for cancer.

Authors:  D Elias; P Lasser; J M Hoang; J Leclere; B Debaene; C Bognel; A Spencer; P Rougier
Journal:  Br J Surg       Date:  1993-12       Impact factor: 6.939

9.  Preoperative portal vein embolization for extended hepatectomy.

Authors:  Alan W Hemming; Alan I Reed; Richard J Howard; Shiro Fujita; Steven N Hochwald; James G Caridi; Irvin F Hawkins; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

10.  Phase I study of individualized stereotactic body radiotherapy of liver metastases.

Authors:  Mark T Lee; John J Kim; Robert Dinniwell; James Brierley; Gina Lockwood; Rebecca Wong; Bernard Cummings; Jolie Ringash; Regina V Tse; Jennifer J Knox; Laura A Dawson
Journal:  J Clin Oncol       Date:  2009-03-02       Impact factor: 44.544

View more
  2 in total

1.  Treatment outcome of hepatic re-irradiation in patients with hepatocellular carcinoma.

Authors:  Seung Won Seol; Jeong Il Yu; Hee Chul Park; Do Hoon Lim; Dongryul Oh; Jae Myoung Noh; Won Kyung Cho; Seung Woon Paik
Journal:  Radiat Oncol J       Date:  2015-12-30

2.  Significant symptoms alleviation and tumor volume reduction after combined simultaneously integrated inner-escalated boost and volumetric-modulated arc radiotherapy in a patient with unresectable bulky hepatocellular carcinoma: A care-compliant case report.

Authors:  Young-Hsiang Lin; Shih-Kai Hung; Wen-Yen Chiou; Moon-Sing Lee; Bing-Jie Shen; Liang-Cheng Chen; Dai-Wei Liu; Wei-Ta Tsai; Po-Hao Lin; Yi-Ting Shih; Feng-Chun Hsu; Shiang-Jiun Tsai; Michael W Y Chan; Hon-Yi Lin
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.